{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:20:18Z","timestamp":1762356018926,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL129948"],"award-info":[{"award-number":["T32HL129948"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.jvca.2021.07.024","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:40:13Z","timestamp":1626439213000},"page":"2143-2153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative Implications of the 2020 American Heart Association\/American College of Cardiology Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Focused Review"],"prefix":"10.1053","volume":"36","author":[{"given":"Dylan R.","family":"Addis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Townsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.07.024_bib0001","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2021.07.024_bib0002","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.07.024_bib0003","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0004","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0005","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0006","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0007","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.07.024_bib0008","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0009","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0010","first-page":"e282","volume":"134","author":"Yancy","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0011","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0012","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0013","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjcard.2013.11.062","article-title":"Heart rate recovery in patients with hypertrophic cardiomyopathy","volume":"113","author":"Patel","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0014","first-page":"e584","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0015","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0016","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1161\/CIR.0b013e318276ce9b","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0017","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0018","first-page":"e382","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0019","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: A guideline from the American Heart Association","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0020","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0021","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0002-9149(02)02694-2","article-title":"Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy","volume":"90","author":"Ommen","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0022","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0894-7317(00)90026-9","article-title":"Apical hypertrophic cardiomyopathy: Echocardiographic diagnosis with the use of intravenous contrast image enhancement","volume":"13","author":"Thanigaraj","year":"2000","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.echo.2017.11.013","article-title":"Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update","volume":"31","author":"Porter","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0024","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.07.024_bib0025","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0026","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.echo.2018.01.022","article-title":"Standardized goal-directed valsalva maneuver for assessment of inducible left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"31","author":"Kumar","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.echo.2010.10.006","article-title":"Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: The range of gradients with upright activity","volume":"24","author":"Joshi","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0028","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.amjcard.2017.08.047","article-title":"Comparison of valsalva maneuver, amyl nitrite, and exercise echocardiography to demonstrate latent left ventricular outflow obstruction in hypertrophic cardiomyopathy","volume":"120","author":"Ayoub","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","volume":"24","author":"Nagueh","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.07.024_bib0031","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1213\/ANE.0000000000000196","article-title":"Echocardiographic assessment of systolic anterior motion of the mitral valve","volume":"118","author":"Hymel","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.07.024_bib0032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0735-1097(92)90135-A","article-title":"Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making","volume":"20","author":"Grigg","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0033","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0735-1097(92)90359-U","article-title":"Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy","volume":"20","author":"Marwick","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0034","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.echo.2017.11.016","article-title":"Intraoperative two- and three-dimensional transesophageal echocardiography in combined myectomy-mitral operations for hypertrophic cardiomyopathy","volume":"31","author":"Nampiaparampil","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.echo.2019.08.021","article-title":"Intraoperative provocative testing in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy","volume":"33","author":"Bedair Elsayes","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1053\/j.jvca.2021.07.024_bib0036","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/euhj.1999.1692","volume":"20","author":"Kuhn","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.07.024_bib0037","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0038","first-page":"1994","article-title":"Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery","volume":"38","author":"Qin","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0039","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","article-title":"Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Managing the risk of procedure-related AV conduction disturbances","volume":"119","author":"Faber","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0041","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1053\/j.jvca.2021.07.024_bib0042","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0043","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0044","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005372","article-title":"How to image hypertrophic cardiomyopathy","volume":"10","author":"Maron","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2021.07.024_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006309","article-title":"Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy","volume":"10","author":"Hindieh","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0047","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-016-0858-4","article-title":"Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: A comparison between cardiac magnetic resonance imaging and echocardiography","volume":"32","author":"Corona-Villalobos","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0048","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003132","article-title":"Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: Implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography","volume":"8","author":"Patel","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2018.06.055","article-title":"Clinical spectrum and management implications of left ventricular outflow obstruction with mild ventricular septal thickness in hypertrophic cardiomyopathy","volume":"122","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0051","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: A test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0052","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/hrt.2007.118018","article-title":"Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"94","author":"Kwon","year":"2008","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2021.07.024_bib0053","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.amjcard.2013.01.340","article-title":"Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management","volume":"111","author":"Rowin","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0054","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.yjmcc.2011.08.028","article-title":"The coronary circulation and blood flow in left ventricular hypertrophy","volume":"52","author":"Camici","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10741-018-9752-6","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: Prevalence, clinical impact, and management","volume":"24","author":"Garg","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.jvca.2021.07.024_bib0056","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0057","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjsports-2016-097438","article-title":"Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: Comparison between the European Society of Cardiology (2010) and International (2017) criteria","volume":"52","author":"Zorzi","year":"2018","journal-title":"Br J Sports Med"},{"key":"10.1053\/j.jvca.2021.07.024_bib0058","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0059","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1053\/j.jvca.2020.06.077","article-title":"Imaging considerations for the athletically conditioned heart: An echocardiography-focused overview of the 2020 American Society of Echocardiography recommendations on the use of multimodality cardiovascular imaging in young adult competitive athletes","volume":"34","author":"Addis","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.07.024_bib0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1213\/ANE.0000000000000538","article-title":"Hypertrophic cardiomyopathy: A review","volume":"120","author":"Hensley","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.07.024_bib0061","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0062","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2014.07.075","article-title":"Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010])","volume":"114","author":"Panaich","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0063","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0064","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000504215","article-title":"Impact of septal myectomy volume on mitral-valve replacement rate in hypertrophic cardiomyopathy patients","volume":"145","author":"Polanco","year":"2020","journal-title":"Cardiology"},{"key":"10.1053\/j.jvca.2021.07.024_bib0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mayocp.2018.07.022","article-title":"Septal myectomy in hypertrophic cardiomyopathy: National outcomes of concomitant mitral surgery","volume":"94","author":"Holst","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.jvca.2021.07.024_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2018.10.002","article-title":"Significance of pulmonary hypertension in hypertrophic cardiomyopathy","volume":"45","author":"Mitra","year":"2020","journal-title":"Curr Probl Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0067","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ehjci\/jew024","article-title":"Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy","volume":"17","author":"Ong","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0068","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2013.08.010","article-title":"Exercise echocardiography in asymptomatic HCM: Exercise capacity, and not LV outflow tract gradient predicts long-term outcomes","volume":"7","author":"Desai","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.jvca.2021.07.024_bib0069","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.athoracsur.2018.03.039","article-title":"Determinants of reverse remodeling of the left atrium after transaortic myectomy","volume":"106","author":"Nguyen","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.07.024_bib0070","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/echo.13158","article-title":"Impact of septal reduction on left atrial size and diastole in hypertrophic cardiomyopathy","volume":"33","author":"Finocchiaro","year":"2016","journal-title":"Echocardiography"},{"key":"10.1053\/j.jvca.2021.07.024_bib0071","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/eht537","article-title":"Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy","volume":"35","author":"Geske","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.07.024_bib0072","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2017.06.071","article-title":"Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis","volume":"243","author":"Pelliccia","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0073","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.112.104638","article-title":"Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: A report from the Pediatric Cardiomyopathy Registry","volume":"126","author":"Webber","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0074","article-title":"Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure [e-pub ahead of print]","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.07.024_bib0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2021.07.024_bib0076","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2021.07.024_bib0077","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chest.2018.11.009","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: A nationwide cohort study","volume":"155","author":"Jung","year":"2019","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.07.024_bib0078","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.07.024_bib0079","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","article-title":"Clinician's guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association","volume":"122","author":"Balady","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.024_bib0080","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.07.024_bib0081","doi-asserted-by":"crossref","first-page":"77e1","DOI":"10.1016\/j.ajog.2019.07.019","article-title":"Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease","volume":"222","author":"Easter","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.jvca.2021.07.024_bib0082","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12471-012-0358-7","article-title":"Pregnancy in women with hypertrophic cardiomyopathy","volume":"21","author":"Pieper","year":"2013","journal-title":"Neth Heart J"},{"key":"10.1053\/j.jvca.2021.07.024_bib0083","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021006054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021006054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:10:55Z","timestamp":1762355455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021006054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1053077021006054"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.07.024","relation":{},"ISSN":["1053-0770"],"issn-type":[{"type":"print","value":"1053-0770"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Implications of the 2020 American Heart Association\/American College of Cardiology Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Focused Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}